Mayne Pharma Group Ltd (MYX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2010 | 06-2009 | 06-2008 | 06-2007 | |
| Sales | 35,428 | N/A | N/A | N/A |
| Cost of Goods | 7,859 | N/A | N/A | N/A |
| Gross Profit | 27,569 | N/A | N/A | N/A |
| Operating Expenses | 26,755 | 5,165 | 4,232 | 1,964 |
| Operating Income | 814 | -5,165 | -4,232 | -1,964 |
| Interest Expense | 1,480 | N/A | N/A | N/A |
| Other Income | 1,271 | 1,040 | 759 | 140 |
| Pre-tax Income | 605 | -4,125 | -3,473 | -1,824 |
| Income Tax | -2,648 | -364 | 0 | 0 |
| Net Income Continuous | 3,253 | -3,761 | -3,473 | -1,824 |
| Net Income | $3,253 | $-3,761 | $-3,473 | $-1,824 |
| EPS Basic Total Ops | 0.38 | -0.71 | -0.65 | -0.59 |
| EPS Basic Continuous Ops | 0.38 | -0.71 | -0.65 | -0.59 |
| EPS Diluted Total Ops | 0.37 | -0.71 | -0.65 | -0.59 |
| EPS Diluted Continuous Ops | 0.37 | -0.71 | -0.65 | -0.59 |
| EBITDA(a) | $8,695 | $-5,138 | $-4,210 | $-1,959 |